about
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease.Biology of chronic graft-vs-host disease: Immune mechanisms and progress in biomarker discovery.Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality.Editorial: Danger Signals Triggering Immune Response and Inflammation.Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.Diagnostic and Prognostic Plasma Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation.Biomarkers in chronic graft-versus-host disease: quo vadis?Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402.Changes in protein serum levels during stem cell transplantation.Patients with Treatment-Requiring Chronic Graft versus Host Disease after Allogeneic Stem Cell Transplantation Have Altered Metabolic Profiles due to the Disease and Immunosuppressive Therapy: Potential Implication for Biomarkers.Application of proteomics to graft-versus-host disease: from biomarker discovery to potential clinical applications.Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease.The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation.Biomarkers for post-transplantation outcomes.Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence.Unraveling the Mechanisms of Cutaneous Graft-Versus-Host Disease.How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD
P2860
Q33593742-5DD73BA7-ED61-44D8-97EE-193855F6F0E6Q33798102-2CB6A118-B6A3-4243-A7F1-0F236F3405AAQ33809599-34100D0D-4797-4C02-A8DD-DA8EB98B6F39Q37522548-6867B08A-8918-46C7-B656-F335C2E1D7B6Q37585022-C84D4D73-8A3E-4D4C-9FD5-3CF2EBFD8CE3Q37587724-C6AA9B16-0BE7-4A12-91E5-A9A00DEA455FQ38798545-8FDB821B-A346-484C-B586-7CABF6545357Q42345013-8F4032EC-4CC6-45F6-A88D-D3909E3DB4EBQ42737499-F1380F8B-6651-48A1-B8A2-04374C33F897Q47312420-E30109E9-1EE1-471A-AE5E-F2DF9120269AQ47713449-E8809893-8079-4C1D-B508-5F28ECB2B2BDQ47743495-1D259443-E986-4C6F-B53C-E7A2DA46DDAFQ47969259-E106493B-9C45-4F02-9FC5-14CA625F8995Q49464975-199E4613-49FF-4939-89D3-6D572488E85DQ49645938-D7A67122-6BBA-49D2-A4FC-4FDEBEC9AC9EQ49954477-E1DF03B1-A211-4148-90B6-E723509269D4Q51028682-4667AB65-AF77-482F-811E-F3A859021005Q51455474-E4497180-42C5-4646-944F-9F67CDF11428Q52603913-298897B2-8AB9-4C96-A4D7-65C3C3D5F51EQ55045366-A6FB381B-FC9C-4149-817C-8793790393F4Q55375763-DB3AAD90-A019-40EF-B831-5554BB8C111EQ58782275-B324E130-9BF1-4067-8D77-920B8BDF3F24
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomarker Panel for Chronic Graft-Versus-Host Disease.
@en
Biomarker Panel for Chronic Graft-Versus-Host Disease.
@nl
type
label
Biomarker Panel for Chronic Graft-Versus-Host Disease.
@en
Biomarker Panel for Chronic Graft-Versus-Host Disease.
@nl
prefLabel
Biomarker Panel for Chronic Graft-Versus-Host Disease.
@en
Biomarker Panel for Chronic Graft-Versus-Host Disease.
@nl
P2093
P2860
P356
P1476
Biomarker Panel for Chronic Graft-Versus-Host Disease.
@en
P2093
Betty K Hamilton
Corey Cutler
George L Chen
Iskra Pusic
Jeffrey Yu
John A Hansen
Joseph Pidala
Kushi Kushekhar
Madan Jagasia
Mary E Flowers
P2860
P304
P356
10.1200/JCO.2015.65.9615
P407
P577
2016-05-23T00:00:00Z